Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/1999
03/09/1999US5879675 Opsonizing tumor cell obtained from animal by incubating in presence of alpha-galactosyl epitope and glycosphingolipids to insert epitope into cell membrane, irradiating cell, administering to animal
03/09/1999CA2038279C Cd25 binding molecules
03/08/1999CA2242476A1 Novel compositions containing cyclosporin
03/04/1999WO1999010502A1 Human nucleotide pyrophosphohydrolase
03/04/1999WO1999010494A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
03/04/1999WO1999010480A2 New tissue-specific calpaines, their production and their use
03/04/1999WO1999010476A1 Immunity enhancing lactic acid bacteria
03/04/1999WO1999010375A2 Vaccine against hpv
03/04/1999WO1999010363A1 29 human secreted proteins
03/04/1999WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
03/04/1999WO1999010308A1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
03/04/1999WO1999010014A2 Receptor-mediated gene delivery using bacteriophage vectors
03/04/1999WO1999010012A1 NOVEL priA
03/04/1999WO1999010009A1 A process for inhibiting complement activation via the alternative pathway
03/04/1999WO1999010008A1 Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
03/04/1999WO1999009991A1 Novel amide derivatives
03/04/1999WO1999009984A1 Pyrrolidine and piperidine modulators of chemokine receptor activity
03/04/1999WO1999009969A1 Treatment of cell-mediated immune diseases
03/04/1999WO1999009957A1 Pharmaceutical composition for combination of piperidinoalkanol-decongestant
03/04/1999DE19737105A1 Neue gewebsspezifische Calpaine, ihre Herstellung und Verwendung New tissue-specific calpain, their preparation and use
03/04/1999CA2654522A1 Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as exipient
03/04/1999CA2302387A1 29 human secreted proteins
03/04/1999CA2302317A1 A process for inhibiting complement activation via the alternative pathway
03/04/1999CA2302293A1 Receptor-mediated gene delivery using bacteriophage vectors
03/04/1999CA2301815A1 New tissue-specific calpaines, their production and their use
03/04/1999CA2301661A1 Human nucleotide pyrophosphohydrolase
03/04/1999CA2301566A1 N-acylated lipophilic amino acid derivatives
03/04/1999CA2298813A1 Pyrrolidine and piperidine modulators of chemokine receptor activity
03/04/1999CA2242254A1 Novel tig
03/03/1999EP0899338A2 Seryl tRNA synthetase of Streptococcus pneumoniae (serS)
03/03/1999EP0899332A2 The G-protein coupled receptor HFIAO41
03/03/1999EP0899261A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists
03/03/1999EP0898579A1 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
03/03/1999EP0898578A1 STREPTOCOCCUS PNEUMONIAE TYROSYL-tRNA SYNTHETASE
03/03/1999EP0898577A1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE
03/03/1999EP0898559A2 Cytoprotective compounds
03/03/1999EP0898478A1 Stimulation of host defence mechanisms against tumors
03/03/1999EP0777666B1 Substituted piperidines useful for the treatment of allergic diseases
03/03/1999EP0737194B1 Diazabicyclic neurokinin antagonists
03/03/1999EP0731791B1 benzenesulfonylimine derivatives as inhibitors of il-1 action
03/03/1999EP0724570B1 Amidino derivatives useful as nitric oxide synthase inhibitors
03/03/1999EP0674641B1 Pyrrolopyrimidines as crf antagonists
03/03/1999EP0673420B1 Mammalian receptors for interleukin-10 (il-10)
03/03/1999EP0616537B1 CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS
03/03/1999CN1209876A Isolated tyrosinase derived peptides and uses thereof
03/03/1999CN1209809A Noval chemical compound
03/03/1999CN1209751A Improved concentrated injection and infusion solutions for intravenous administration
03/03/1999CN1209548A Method for preparing carbide resin DNA immunity adsorbent
03/02/1999US5877342 Skin disorders; respiratory system disorders; cardiovascular disorders
03/02/1999US5877321 Neurokinin receptor
03/02/1999US5877302 Compacted nucleic acids and their delivery to cells
03/02/1999US5877282 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
03/02/1999US5877210 Controlling immune response
03/02/1999US5877193 Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
03/02/1999US5877190 Substituted biphenyl compounds
03/02/1999US5877187 Benzimidazole derivatives with antihistaminic activity
03/02/1999US5877176 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
03/02/1999US5877017 Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereof
03/02/1999US5877010 Thymidine kinase mutants
03/02/1999US5876966 Compounds and methods for the stimulation and enhancement of protective immune responses and IL-12 production
03/02/1999US5876963 Human nucleotide pyrophosphohydrolase
03/02/1999US5876950 Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
03/02/1999US5876749 Pharmaceutical composition
03/02/1999US5876737 Use of salicin as an anti-irritative active compound in cosmetic and topical dermatological preparations
03/02/1999US5876735 Methods for enhancement of protective immune responses
03/02/1999US5876727 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
03/02/1999US5876726 Vaccines and methods for preventing and treating fescue toxicosis in herbivores
03/02/1999US5876723 Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition
03/02/1999US5876722 Hybrid protein
03/02/1999US5876721 Vaccines
03/02/1999US5876718 Using antibodies which bind to protein
03/02/1999US5876717 Prevent rejection of organ transplantation and also to cure autoimmune diseases.
03/02/1999US5876709 Ophthalmic composition containing active Vitamin D
03/02/1999CA2175458C Novel benzenesulfonylimine derivatives as inhibitors of il-1 action
02/1999
02/27/1999CA2233681A1 Novel div1b
02/25/1999WO1999009171A1 Ubc7-like ubiquitin-conjugating enzyme
02/25/1999WO1999009162A2 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999WO1999009064A1 Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules
02/25/1999WO1999009061A1 Secreted proteins
02/25/1999WO1999009054A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
02/25/1999WO1999009022A1 Furansulfonic acid derivatives and pharmaceutical compositions containing the same
02/25/1999WO1999009005A1 Hiv matrix protein tyrosine position 29 pocket binders
02/25/1999WO1999008713A1 Vaccination by topical application of genetic vectors
02/25/1999WO1999008707A1 Preventives and/or remedies for systemic lupus erythematosus containing anti-il-6 receptor antibody as the active ingredient
02/25/1999WO1999008706A1 Recombinant porcine adenovirus vector
02/25/1999WO1999008703A1 Anti-viral treatment with pertussis toxin b oligomer
02/25/1999WO1999008694A1 Immunostimulatory and metastasis inhibiting fermented vegetal material
02/25/1999WO1999008690A1 Method of enhancing bioavailability of fexofenadine and its derivatives
02/25/1999WO1998053050A3 Short peptides which selectively modulate the activity of serine/threonine kinases
02/25/1999WO1998052915A3 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists
02/25/1999WO1998052582A3 Non-myeloablative tolerogenic treatment
02/25/1999WO1998047866A3 Arylsecocholadiene derivatives
02/25/1999WO1998042659A3 Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivates, process for their preparation and their use as pharmaceuticals
02/25/1999DE19837386A1 New CCR-3 antagonist piperazine derivatives and analogues
02/25/1999CA2301328A1 Vaccination by topical application of genetic vectors
02/25/1999CA2300918A1 Ubc7-like ubiquitin-conjugating enzyme
02/25/1999CA2300694A1 Furansulfonic acid derivatives and pharmaceutical compositions containing the same
02/25/1999CA2300431A1 Anti-viral treatment with pertussis toxin b oligomer
02/25/1999CA2300093A1 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999CA2298866A1 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
1 ... 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 ... 1172